Officer Files Intent to Sell Nearly $480K in Company Stock
PACB sits 88% above its 52-week low of $0.851.
Summary
An officer of Pacific Biosciences of California, Inc. has filed a Form 144 to sell approximately $478,692 worth of common stock, representing about 0.1% of the company's market cap.
Key Events · Ownership and Investor Activity · PACB
-
Officer Files Intent to Sell
Mark Van Oene, an officer, filed a Form 144 to sell 303,739 shares of common stock.
-
Significant Value
The proposed sale has an approximate market value of $478,692.66.
-
Post-Earnings Timing
This intent to sell follows the company's recent report of better-than-expected Q4 results on February 12, 2026.
Analysis · PACB · Industrial Applications And Services
Mark Van Oene, an officer at Pacific Biosciences, has filed a Form 144 indicating an intent to sell approximately $478,692 worth of common stock. This proposed sale represents about 0.1% of the company's current market capitalization. The filing comes shortly after the company reported better-than-expected Q4 results on February 12, 2026, and completed a significant asset sale to Illumina on February 2, 2026. While the amount is not exceptionally large, an officer's intent to sell can be viewed as a slightly negative signal, especially following recent positive corporate news.
At the time of this filing, PACB was trading at $1.60 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $477M. The 52-week trading range was $0.85 to $2.73. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.